Company intelligence
QurieGen
Revolutionizing the way we discover drugs
About QurieGen
QurieGen is a Dutch techbio company building “Google Maps for cells” to derisk and accelerate drug discovery and development. Our secret sauce is the data and models. We generate proprietary single-cell multi-omics data using our in-house built technologies, and we feed this unique, high-resolution dataset into our AI models. This allows us to build mechanistic, interpretable virtual cell models that simulate how signals move through pathways and predict how drugs reshape cellular systems. Because we control both the data layer and the modeling layer, we can go far beyond black-box predictions.
Verified activity
Signals from QurieGen
9 published signals
Presence & Recognition
QurieGen was named one of 17 European deeptech startups to watch by Tech Funding News based on nominations from leading European VCs.
Reported by QurieGen
Presence & Recognition
QurieGen was selected among 17 European deeptech startups to watch based on nominations from leading European investors.
Reported by Kinga Matuła, PhD eng
Presence & Recognition
QurieGen has been named one of 17 European deeptech startups to watch by Tech Funding News
Reported by Kinga Matuła, PhD eng
Presence & Recognition
QurieGen Signal Scan is back after its summer break.
Reported by Kinga Matuła, PhD eng
Presence & Recognition
QurieGen is now part of the Fall 2026 MassBio Drive TechBio program.
Reported by QurieGen
Presence & Recognition
QurieGen is directly accessing pharma expertise through the Fall 2026 MassBio Drive TechBio Cohort.
Reported by QurieGen
Presence & Recognition
QurieGen has been selected as one of five companies for the Fall 2026 MassBio Drive TechBio Cohort.
Reported by QurieGen
Presence & Recognition
QurieGen joined the Fall 2026 MassBioio Drive TechBio Cohort in the United States.
Reported by Kinga Matuła, PhD eng
Presence & Recognition
QurieGen has been selected as one of just five companies for the Fall 2026 MassBio Drive TechBio Cohort.
Reported by Kinga Matuła, PhD eng